National Comprehensive Cancer network (2022) NCCN guidelines; prostate cancer version 4. 2022. In: The category of prostate cancer. https://www.nccn.org/guidelines/category_1. Accessed 10 May 2022

Hatano K, Tohyama N, Kodama T et al (2019) Current status of intensity-modulated radiation therapy for prostate cancer: history, clinical results and future directions. Int J Urol 26(8):775–784. https://doi.org/10.1111/iju.14011

Article  PubMed  Google Scholar 

Wang S, Tang W, Luo H et al (2023) The role of image-guided radiotherapy in prostate cancer: a systematic review and meta-analysis. Clin Transl Radiat Oncol 38:81–89. https://doi.org/10.1016/j.ctro.2022.11.001

Article  CAS  PubMed  Google Scholar 

Barney BM, Lee RJ, Handrahan D et al (2011) Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys 80(1):301–305. https://doi.org/10.1016/j.ijrobp.2010.06.007

Article  PubMed  Google Scholar 

de Crevoisier R, Bayar MA, Pommier P et al (2018) Daily versus weekly prostate cancer image-guided radiotherapy: phase 3 multicenter randomized trial. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2018.07.2006

Article  PubMed  Google Scholar 

Zelefsky MJ, Kollmeier M, Cox B et al (2012) Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 84(1):125–129. https://doi.org/10.1016/j.ijrobp.2011.11.047

Article  PubMed  Google Scholar 

Wilcox SW, Aherne NJ, McLachlan CS et al (2015) Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series. J Med Imaging Radiat Oncol 59(1):125–133. https://doi.org/10.1111/1754-9485.12275

Article  PubMed  Google Scholar 

Kok D, Gill S, Bressel M et al (2013) Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy. Radiother Oncol 107(2):140–146. https://doi.org/10.1016/j.radonc.2013.04.007

Article  PubMed  Google Scholar 

Valeriani M, Bracci S, Osti MF et al (2013) Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy. Radiat Oncol 8:137. https://doi.org/10.1186/1748-717X-8-137

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura K, Mizowaki T, Inokuchi H et al (2017) Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance. Int J Clin Oncol. https://doi.org/10.1007/s10147-017-1174-2

Article  PubMed  PubMed Central  Google Scholar 

Napieralska A, Majewski W, Kulik R et al (2018) A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients. Radiat Oncol 13(1):235. https://doi.org/10.1186/s13014-018-1171-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Q, Gao H, Li G et al (2014) Significance of image guidance to clinical outcomes for localized prostate cancer. Biomed Res Int 2014:860639. https://doi.org/10.1155/2014/860639

Article  PubMed  PubMed Central  Google Scholar 

Kuo YH, Liang JA, Chen GH et al (2021) Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis. Br J Radiol 94(1121):20200456. https://doi.org/10.1259/bjr.20200456

Article  PubMed  PubMed Central  Google Scholar 

Jereczek-Fossa BA, Surgo A, Maisonneuve P et al (2019) Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation. Radiol Med 124(1):65–78. https://doi.org/10.1007/s11547-018-0937-9

Article  PubMed  Google Scholar 

D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974. https://doi.org/10.1001/jama.280.11.969

Article  CAS  PubMed  Google Scholar 

Aizawa R, Takayama K, Nakamura K et al (2020) Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy. Int J Clin Oncol 25(4):713–719. https://doi.org/10.1007/s10147-019-01596-7

Article  CAS  PubMed  Google Scholar 

Uto M, Mizowaki T, Ogura K et al (2017) Volumetric modulated dynamic wavearc therapy reduces the dose to the hippocampus in patients with pituitary adenomas and craniopharyngiomas. Pract Radiat Oncol 7(6):382–387. https://doi.org/10.1016/j.prro.2017.04.004

Article  PubMed  Google Scholar 

Mizowaki T, Norihisa Y, Takayama K et al (2016) Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c–T2N0M0 prostate cancer. Int J Clin Oncol 21(4):783–790. https://doi.org/10.1007/s10147-016-0954-4

Article  CAS  PubMed  Google Scholar 

Roach M III, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974. https://doi.org/10.1016/j.ijrobp.2006.04.029

Article  PubMed  Google Scholar 

Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244

Article  CAS  PubMed  Google Scholar 

Das S, Liu T, Jani AB et al (2014) Comparison of image-guided radiotherapy technologies for prostate cancer. Am J Clin Oncol 37(6):616–623. https://doi.org/10.1097/COC.0b013e31827e4eb9

Article  PubMed  Google Scholar 

Morris WJ, Tyldesley S, Rodda S et al (2017) Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 98(2):275–285. https://doi.org/10.1016/j.ijrobp.2016.11.026

Article  PubMed  Google Scholar 

Ishiyama H, Kamitani N, Kawamura H et al (2017) Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium. Brachytherapy 16(3):503–510. https://doi.org/10.1016/j.brachy.2017.01.006

Article  PubMed  Google Scholar 

Nihei K, Nakamura K, Karasawa K et al (2021) A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2021.07.917

Article  Google Scholar